Skip to main content
Sona Nanotech Inc. logo

Sona Nanotech Inc. — Investor Relations & Filings

Ticker · SONA ISIN · CA83541C1059 CSE Professional, scientific and technical activities
Open in API
Filings indexed 424 across all filing types
Latest filing 2020-03-18 Regulatory Filings
Country CA Canada
Listing CSE SONA

About Sona Nanotech Inc.

https://www.sonanano.com/

Sona Nanotech Inc. is a life sciences company specializing in the development and commercialization of proprietary, uniquely biocompatible gold nanorod (GNR) technology. The primary therapeutic focus is Targeted Hyperthermia Therapy (THT), a photothermal cancer treatment utilizing GNRs to deliver precision heat directly to solid tumors. THT is designed to reduce tumor burden and stimulate immunogenic cell death while minimizing harm to healthy tissue. Sona is advancing THT through clinical trials for solid cancers, including melanoma. Furthermore, the company manufactures and supplies its patented, CTAB-free gold nanoparticles (nanorods and nanospheres) for integration into advanced materials science and medical diagnostic applications, such as lateral flow assays.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a press release providing an update on the development of a Covid-19 test by Sona Nanotech Inc. It discusses milestones achieved, ongoing discussions with health departments, and future plans. There are no financial statements, regulatory filings, or detailed financial data. The content is an operational update and corporate news rather than a formal financial report or regulatory filing. It does not fit into categories like Annual Report, Interim Report, Earnings Release, or Regulatory Filings. It is a general corporate update announcement, best classified under Regulatory Filings (RNS) as a miscellaneous announcement that does not fit other specific categories.
2020-03-18 English
Annual information form - English.pdf
Regulatory Filings
2020-03-18 English
News release - English.pdf
Director's Dealing Classification · 95% confidence The document is a press release announcing the granting of stock options to directors and officers under the company's stock option plan. It details the number of options granted, exercise price, vesting schedule, and expiration. There is no financial report, earnings data, or detailed management discussion. The document is an announcement related to share-based compensation, specifically about stock options granted to insiders. This fits the category of Director's Dealing (DIRS), which covers reports of personal share transactions by company directors and executives. The document length is short and it is not a report or filing of financial results, so it is not an Annual Report, Earnings Release, or similar. Therefore, the correct classification is DIRS with high confidence.
2020-03-17 English
News release - English.pdf
Regulatory Filings
2020-03-12 English
Notice of the meeting and record date - French.pdf
Regulatory Filings
2020-03-10 English
News release - English.pdf
Regulatory Filings
2020-03-06 English

Browse filings by year

21 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.